常寶股份(002478.SZ)上半年淨利預降46.52%-59.89%
格隆匯7月14日丨常寶股份(002478.SZ)披露2021年半年度業績預吿,公司預計2021年1-6月實現歸屬於上市公司股東的淨利潤0.90億元-1.20億元,同比下降59.89%-46.52%。
2021年半年度經營業績較去年同期出現較大幅度的下降,主要原因為公司能源管材板塊上游原料價格整體大幅上漲給公司經營帶來不利影響,原料價格上漲幅度大於產品價格上漲,導致產品毛利率下滑,同時受新冠疫情持續影響,國外市場需求下滑,加上出口退税等政策影響,從而導致2021半年度經營業績同比下滑。
預計公司在報吿期內處理醫療資產計入的非經常性損益的金額為7365萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.